New Haven, CONNECTICUT2 Active Studies

Substance Use Disorder Clinical Trials in New Haven, CONNECTICUT

Find 2 actively recruiting substance use disorder clinical trials in New Haven, CONNECTICUT. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
250
Enrolling

Recruiting Substance Use Disorder Studies in New Haven

About Substance Use Disorder Clinical Trials in New Haven

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 2 substance use disorder clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 250 participants. Research is being sponsored by Yale University, Altimmune, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in New Haven — FAQ

Are there substance use disorder clinical trials in New Haven?

Yes, there are 2 substance use disorder clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov